China Signals Openness to Deal Allowing TikTok to Remain in US Citi Initiates Coverage of NextDecade NEXT with Buy Rating Sees 30 Upside USChina Trade Rift Persists APEC Meetings Reveal Lingering Disagreements Millions of Americans May Still Be Eligible for PandemicEra IRS Refund Heres How to Check NTPC Q4 Results Consolidated Profit Surges 34 YoY to 10615 Crore Board Declares 35Share Final Dividend Nvidia Boosts Dividend and Buybacks Amid Surging Free Cash Flow Valuation Could Offer Upside AQST Q1 2026 Earnings NarrowerThanExpected Loss Drives Positive Surprise INTR Q1 2026 Earnings EPS Falls Short of Estimates Stock Slides 375 ICHR Q1 2026 Earnings EPS Surpasses Expectations Stock Rises BQ Q4 2022 Earnings NarrowerthanExpected Loss Lifts Sentiment Fortis Inc FTS Q1 2026 Earnings EPS Slightly Misses Estimates Shares Edge Higher Rapid7 Q1 2026 Earnings Strong EPS Beat Drives Positive Market Reaction SIM Acquisition Corp I SIMA Holds Steady at 1076 as Market Awaits Catalyst Dillards DDS Stages a Modest Recovery Testing Key Resistance Levels MidCap Financial Investment Notes MFICL Edges Higher 2682 Resistance in Focus Crown Crafts Inc CRWS Posts Modest Gain Tests Key Resistance Zone Brazil Potash Corp GRO Faces Selling Pressure as Stock Drops Near Support Your Bond Portfolio May Be Facing a Termite Infestation Worse Than Jamie Dimons Cockroaches ICG Q4 2025 Earnings Massive EPS Miss Shakes Investor Confidence Snail Inc SNAL Retreats to 092 as Selling Pressure Intensifies ZD Q1 2026 Earnings EPS Misses Estimates Stock Rises on Strategic Progress Braemar Hotels Resorts BHR Q1 2026 Earnings Stunning EPS Surprise of 42178 on a Loss Estimate American States Water Company AWR Q1 2026 Earnings EPS Misses Estimates Despite Slight Stock Gain FIGS Q1 2026 Earnings Strong EPS Surprise Highlights Margin Improvement HSDT Q1 2026 Earnings Significant EPS Miss Raises Concern Over Profitability Immunome Q1 2026 Earnings NarrowerThanExpected Loss as Pipeline Progress Continues Immatics NV IMTX Q1 2026 Earnings EPS Misses Estimates as Clinical Progress Drives Share Gains